Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance) Meeting Abstract


Authors: Sikov, W. M.; Berry, D. A.; Perou, C. M.; Singh, B.; Cirrincione, C. T.; Tolaney, S. M.; Somlo, G.; Port, E. R.; Qamar, R.; Sturtz, K.; Mamounas, E.; Golshan, M.; Bellon, J. R.; Collyar, D.; Hahn, O. M.; Carey, L. A.; Hudis, C. A.; Winer, E. P.
Abstract Title: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)
Meeting Title: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 76
Issue: 4 Suppl.
Meeting Dates: 2015 Dec 8-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2016-02-15
Language: English
ACCESSION: WOS:000375622400342
DOI: 10.1158/1538-7445.sabcs15-s2-05
PROVIDER: wos
Notes: Meeting Abstract: S2-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis